Population Pharmacokinetics of Telavancin in Healthy Subjects and Patients with Infections

Eitemau Tebyg

• Pharmacokinetics of intravenous telavancin in healthy subjects with varying degrees of renal impairment
  gan: Worboys, Philip D., et al.
  Cyhoeddwyd: (2015)
• Intrapulmonary Distribution of Intravenous Telavancin in Healthy Subjects and Effect of Pulmonary Surfactant on In Vitro Activities of Telavancin and Other Antibiotics
  gan: Gotfried, Mark H., et al.
  Cyhoeddwyd: (2008)
• Pharmacokinetics, Serum Inhibitory and Bactericidal Activity, and Safety of Telavancin in Healthy Subjects
  gan: Shaw, J. P., et al.
  Cyhoeddwyd: (2005)
• Tissue Penetration of Telavancin after Intravenous Administration in Healthy Subjects
  gan: Sun, Heather K., et al.
  Cyhoeddwyd: (2006)
• Mass Balance and Pharmacokinetics of [(14)C]Telavancin following Intravenous Administration to Healthy Male Volunteers
  gan: Shaw, Jeng-Pyng, et al.
  Cyhoeddwyd: (2010)